End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
177,400 KRW | -1.17% | +0.17% | -11.96% |
Apr. 24 | Market Share of Celltrion’s Remsima Rises to 74% in Europe | MT |
Apr. 17 | Celltrion, Inc. announces an Equity Buyback for 436,047 shares. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.96% | 26.77B | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.58% | 40.57B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B | |
-18.79% | 9.85B |
- Stock Market
- Equities
- A068270 Stock
- News Celltrion, Inc.
- Britain’s MHRA Clears Celltrion's Cancer Drug Vegzelma for Marketing in the UK